http://patient.cancerconsultants.com/breas...176

This article shows that taxotere ALONE provided a better response than adria ALONE but that survival rates are thus far unaffected. The study cited is ONLY in metastatic women, NOT in the adjuvant population. I do not know offhand how many women were in the study, how the sample was picked. Research for cancer is going on all the time, some of it good, some of it bad, some of it really really bad. One must be careful when citing research and studies that one does not initiate rumors that are taken out of context and are not truly fact-based.